Tenax Therapeutics Inc's Comment on Sales, Marketing and Customers
The company serves customers in the healthcare market, including governmental authorities such as Medicare, private health insurers, and organizations that establish coverage and reimbursement policies. The commercial success of its product candidates depends on third-party payers, including government health programs and commercial insurers, providing appropriate coverage and reimbursement. Compliance with federal and state healthcare laws and regulations, including the federal anti-kickback statute, the federal False Claims Act, the Health Insurance Portability and Accountability Act, the Social Security Act, and analogous state laws, is essential to the company's business operations and market acceptance.
In a major stride towards combatting the debilitating heart condition known as Heart Failure with Preserved Ejection Fraction (HFpEF), Tenax Therapeutics has successfully enrolled the first patient in their groundbreaking Phase 3 study. The clinical trial, named LEVEL, aims to evaluate the effectiveness of TNX-103, an oral medication based on levosimendan, in treating the associated pulmonary hypertension in HFpEF patients.This groundbreaking study has garnered significant interest and support, with over 40 renowned medical institutions across the United States and Canada agreeing to partake in the research. The involvement of these esteemed sites underscores the potential impact TNX-103 may have in revoluti...
Tenax Therapeutics Inc’s Comment on Sales, Marketing and Customers
The company serves customers in the healthcare market, including governmental authorities such as Medicare, private health insurers, and organizations that establish coverage and reimbursement policies. The commercial success of its product candidates depends on third-party payers, including government health programs and commercial insurers, providing appropriate coverage and reimbursement. Compliance with federal and state healthcare laws and regulations, including the federal anti-kickback statute, the federal False Claims Act, the Health Insurance Portability and Accountability Act, the Social Security Act, and analogous state laws, is essential to the company's business operations and market acceptance.
Sources:
Tenax Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Tenax Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Tenax Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
